Removal of boxed warning for menopausal hormone therapy: What nurses need to know.

Q3 Nursing

Nursing Pub Date : 2026-10-01 Epub Date: 2026-09-21 DOI:10.1097/NSG.0000000000000411

Michelle Dang

引用次数: 0

Abstract

Abstract: In November 2025, the Food and Drug Administration removed the boxed warning from menopausal hormone therapy products, marking a significant shift in how clinicians and patients understand the risk-benefit profile of these widely used medications. This change reflects 20 years of evolving evidence since the Women's Health Initiative study and has important implications for nursing practice. This article reviews the evidence behind this regulatory change, clarifies current indications and contraindications for hormone therapy, and provides practical guidance for nurses counseling patients about menopause management options.

查看原文本刊更多论文

解除绝经期激素治疗的黑框警告：护士需要知道的。

摘要：2025年11月，美国食品和药物管理局取消了绝经期激素治疗产品的黑框警告，这标志着临床医生和患者对这些广泛使用的药物的风险-收益概况的理解发生了重大转变。这一变化反映了自妇女健康倡议研究以来20年来不断发展的证据，对护理实践具有重要意义。本文回顾了这一监管变化背后的证据，澄清了激素治疗的当前适应症和禁忌症，并为护士咨询患者更年期管理选择提供了实用指导。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nursing Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

338

期刊介绍： Nursing2020 (ISSN 0360-4039; online ISSN 1538-8689) published its first issue in November 1971, under founders Gene W. Jackson and Daniel Cheney. In the intervening years, its circulation has grown to over 150,000, making it one of the largest nursing journals in the world. Published monthly, Nursing2020 is widely regarded as offering current, practical contents to its readers, and has won many editorial awards testifying to the quality of its copy and graphics. The editorial and clinical staff, a 19-member Editorial Board of distinguished clinicians and practitioners, and over 100 invited reviewers help ensure the quality of this publication.